or
forgot password
  • cancer clinical trials in durham, NC

  • Lenalidomide + Plerixafor in Previously Treated Chronic Lymphocytic Leukemia (CLL)
    Duke University Medical Center
    Durham, North Carolina 27710
    Leukemia, Lymphocytic, Chronic, B-Cell
    A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
    Duke University Medical Center Duke3
    Durham, North Carolina 27710
    Solid Tumors and Advanced Endometrial Cancer, Endometrial Cancer, Second-line Treatment, VEGF
    Pazopanib, Docetaxel, Prednisone Prostate
    Duke Cancer Institute
    Durham, North Carolina 27710
    Prostate Cancer
    BKM120 in Metastatic Castration-resistant Prostate Cancer
    Duke Cancer Institute
    Durham, North Carolina 27710
    Prostate Cancer, Metastatic (Spread to Other Areas of the Body)
    MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
    Duke University Medical Center
    Durham, North Carolina 27710
    Acute Myeloid Leukemia
    Pilot Study to Measure Lung Biopsy Diagnostic Yield Using Always On Electromagnetic Tip Tracked Devices
    Duke University Medical Center
    Durham, North Carolina 27710
    Pulmonary Coin Lesion
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
    Duke University Medical Center
    Durham, North Carolina 27710
    B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, Cognitive/Functional Effects, Neurotoxicity, Pain, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Therapy-related Toxicity, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Study of Tissue Samples From Patients With Non-Small Cell Lung Cancer
    Duke Cancer Institute
    Durham, North Carolina 27710
    Lung Cancer
    PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
    Duke University Medical Center
    Durham, North Carolina 27710
    Metastatic Renal Cell Carcinoma, Metastatic Melanoma
    Phase 1-2 Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer
    Duke University Medical Center
    Durham, North Carolina 27710
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer
    Cancer Vaccines CRS-207 and GVAX Pancreas for Metastatic Pancreatic Adenocarcinoma
    Duke University Medical Center
    Durham, North Carolina 27710
    Pancreatic Cancer
    Patient Controlled Tissue Expansion for Breast Reconstruction
    Duke University Medical Center
    Durham, North Carolina 27710
    Breast Cancer
    Pilot Study of Model Based Iterative Reconstruction Using 64-Slice
    Duke University Medical Center
    Durham, North Carolina 27710
    Posterior Fossa Hemorrhage, Lung Cancer, Flank Pain, Urolithiasis, Focal Hepatic Necrosis
    A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL
    Duke University Medical Center
    Durham, North Carolina 27710
    Acute Lymphoblastic Leukemia (ALL)
    Letrozole in Treating Postmenopausal Women With Ductal Carcinoma in Situ
    Duke Cancer Institute
    Durham, North Carolina 27710
    Breast Cancer
    Safety and Efficacy Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids
    Site Reference ID/Investigator# 55109
    Durham, North Carolina 27713
    Heavy Uterine Bleeding, Uterine Fibroids
    Pharmacokinetics (PK) of TKI258 in Cancer Patients With Normal and Impaired Hepatic Function
    Duke University Medical Center DUMC
    Durham, North Carolina 27710
    Solid Tumors, Hepatic Impairment
    Emend and Ondansetron Compared to Ondansetron Alone to Prevent CINV in Glioma Patients Receiving Temozolomide
    The Preston Robert Tisch Brain Tumor Center at Duke
    Durham, North Carolina 27710
    Nausea, Vomiting, Glioma
    Study of ABT-700 in Subjects With Advanced Solid Tumors
    Site Reference ID/Investigator# 66111
    Durham, North Carolina 27710
    Advanced Solid Tumors
    A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
    Duke University Medical Center, Comprehensive Cancer Center
    Durham, North Carolina
    Pancreatic Cancer
    Mila Blooms Intervention Study
    Duke University Medical Center, Dept. of Community and Family Medicine
    Durham, North Carolina 27705
    Childhood Cancer
    Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
    The Preston Robert Tisch Brain Tumor Center at Duke University Medical Center
    Durham, North Carolina 27710
    Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma, Gliosarcoma, Glioblastoma With Oligodendroglial Component
    Alisertib (MLN8237) or Investigator's Choice in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma
    Duke University Medical Center
    Durham, North Carolina 27710
    Relapsed Peripheral T-Cell Lymphoma, Refractory Peripheral T-Cell Lymphoma
    Safety and Efficacy of Kanglaite Gelcaps in Prostate Cancer
    Duke University
    Durham, North Carolina 27710
    Prostate Cancer
    Dose Escalation Study of Pazopanib Plus TH-302
    Duke Cancer Institute
    Durham, North Carolina 27710
    Solid Tumors
    IIT CTI Bendamustine, Rituximab, Pixantrone in Relapsed/Refractory B Cell Non-Hodgkin's Lymphoma
    Duke University Medical Center
    Durham, North Carolina 27710
    Non-Hodgkin's Lymphoma
    Poliovirus Vaccine for Recurrent Glioblastoma Multiforme (GBM)
    Duke University Medical Center
    Durham, North Carolina 27710
    Recurrent Supratentorial Glioblastoma Multiforme, GBM, Glioblastoma Multiforme
    The BEACON Study (Breast Cancer Outcomes With NKTR-102)
    DUMC, Duke South
    Durham, North Carolina 27710
    Locally Recurrent Breast Cancer, Metastatic Breast Cancer
    HKI-272 for HER2-Positive Breast Cancer and Brain Metastases
    Duke University Medical Center
    Durham, North Carolina 27710
    Breast Cancer
    Zevalin and Velcade in Relapsed/Refractory Mantle Cell Lymphoma
    Duke University Medical Center
    Durham, North Carolina 27710
    Mantle-Cell Lymphoma
    A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
    The Preston Robert Tisch Brain Tumor Center; Duke University Medical Center
    Durham, North Carolina 27710
    Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma, Gliosarcoma, Glioblastoma With Oligodendroglial Component, Recurrent Glioblastoma, Relapsed Glioblastoma
    Minimally Invasive Groin Dissection for Melanoma
    Duke University Medical Center
    Durham, North Carolina 27710
    Melanoma
    Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
    Duke University Medical Center
    Durham, North Carolina 27710
    Metastatic Colorectal Cancer, Colorectal Cancer
    Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome
    Duke University
    Durham, North Carolina 27710
    Lambert-Eaton Myasthenic Syndrome, Eaton-Lambert Myasthenic Syndrome
    The CATCH Prostate Cancer Trial: Cabazitaxel And Tasquinimod in Men With Prostate Cancer
    Duke Cancer Institute
    Durham, North Carolina 27710
    Prostate Cancer
    Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas
    Duke University Medical Center
    Durham, North Carolina 27710
    Childhood Mixed Glioma, Untreated Childhood Anaplastic Astrocytoma, Untreated Childhood Brain Stem Glioma, Untreated Childhood Giant Cell Glioblastoma, Untreated Childhood Glioblastoma, Untreated Childhood Gliosarcoma
    A Phase I Study To Evaluate The Antitumor Activity And Safety Of AVX901
    Duke University Medical Center
    Durham, North Carolina 27710
    HER2+ Cancer
    Phase 3 Study of Fibrocaps™ in Surgical Bleeding
    Duke University Hospital Medical Center
    Durham, North Carolina 27710
    Mild or Moderate Surgical Bleeding
    Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer
    Duke University Medical Center Duke (SC)
    Durham, North Carolina 27710
    Metastatic Breast Cancer
    Veliparib in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
    Duke University Medical Center
    Durham, North Carolina 27710
    BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation
    Pediatric Bone and Cord Blood, Duke Univ. Med. Center
    Durham, North Carolina 27710
    Cord Blood Transplant, Hematologic Malignancy, Inherited Metabolic Disease
    Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors
    Duke University Medical Center Duke - Baker
    Durham, North Carolina 27710
    Dose Escalation, Safety, Preliminary Efficacy, Advanced Solid Tumors, Metastatic Breast Cancer, Advanced Pancreatic Adenocarcinoma, Metastatic Colorectal Cancer, Recurrent Glioblastoma Multiforme
    Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC)
    Duke University Medical Center
    Durham, North Carolina 27710
    Advanced Renal Cell Carcinoma, Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
    Neuroblastoma Biology Study
    Duke University Medical Center
    Durham, North Carolina 27710
    Neuroblastoma
    ch14.18 Pharmacokinetic Study in High-risk Neuroblastoma
    Duke University Medical Center
    Durham, North Carolina 27710
    Neuroblastoma
    Combination Chemotherapy With or Without Rituximab in Treating Younger Patients With Stage III-IV Non-Hodgkin Lymphoma or B-Cell Acute Leukemia
    Duke University Medical Center
    Durham, North Carolina 27710
    B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Diffuse Large Cell Lymphoma, L3 Childhood Acute Lymphoblastic Leukemia, Stage III Childhood Large Cell Lymphoma, Stage IV Childhood Large Cell Lymphoma, Untreated Childhood Acute Lymphoblastic Leukemia
    Phase Ib/II Study of PLX 3397 and Eribulin in Patients With Metastatic Breast Cancer
    Duke University Cancer Center
    Durham, North Carolina 27710
    Metastatic Breast Cancer
    Double Cord Versus Haploidentical (Blood and Marrow Transplant Clinical Trials Network #1101)
    Duke University Medical Center
    Durham, North Carolina 27710
    Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma, Follicular Lymphoma, Hodgkin Lymphoma, Mantle Cell Lymphoma
    Study of MLN8237 in Combination With Irinotecan and Temozolomide
    Duke University Medical Center
    Durham, North Carolina 27710
    Neuroblastoma
    Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)
    UNC - Chapel Hill School of Medicine

    Trial Locations
    UNC - Chapel Hill School of Medicine
    UNC Diabetes Research at Eagle Physicians
    Obesity, Overweight
    Phase II Study of Ipilimumab Monotherapy in Recurrent Platinum Sensitive Ovarian Cancer Patients
    Duke University Medical Center
    Durham, North Carolina 27710
    Ovarian Cancer
    Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients
    Duke University
    Durham, North Carolina 27710
    Cytomegalovirus Infections
    A Study of Necitumumab Monotherapy and the QT/QTc Interval in Patient With Advanced Solid Tumors
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Durham, North Carolina
    Solid Tumors
    Naive T-Cell Depleted DLI Following Allo Stem Cell Transplant
    Duke University Medical Center
    Durham, North Carolina 27710
    Hematological Malignancies
    Integrated Dose Escalation for Advanced, Localized Cervical Cancer (The IDEAL - Cervix Trial)
    Radiation Oncology, DUMC
    Durham, North Carolina 27710
    Cancer of the Cervix, Cervical Neoplasms
    Pilot Study of Bone Marrow/Stem Cells in Grade IV Malignant Glioma
    Duke University Medical Center
    Durham, North Carolina 27710
    Grade IV Malignant Glioma
    Study of BMS-936558 Compared to Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC)
    Duke University Medical Center
    Durham, North Carolina 27710
    Squamous Cell Non-small Cell Lung Cancer
    Phase I/II Study of Capecitabine Plus Aflibercept to Treat Metastatic Colorectal Cancer
    Duke Cancer Center, Duke University Medical Center
    Durham, North Carolina 27710
    Metastatic Colorectal Cancer
    Study of BMS-936558 vs. Everolimus in Pre-Treated Advanced Or Metastatic Clear-cell RCC
    Duke University Medical Center
    Durham, North Carolina 27710
    Advanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell Carcinoma
    BIBF 1120 in Bevacizumab Resistant, Persistent, or Recurrent Epithelial Ovarian Cancer
    Duke Cancer Institute
    Durham, North Carolina 27710
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer
    Neratinib in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer
    Duke Cancer Institute
    Durham, North Carolina 27710
    Breast Neoplasms